CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 35,000 shares at $17.66 ($618,170)
- 4 Shares withheld for taxes SVP & Chief Medical Officer gave up 4,640 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, CFO, Sec & Treasurer gave up 7,124 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 17,772 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale SVP & Chief Commercial Officer sold 107,500 shares at an average $12.03 ($1,293,277)
- 4 Open-market sale President and CEO sold 8,928 shares at $12.07 ($107,784)
- 4 Open-market sale SVP, CFO, Sec & Treasurer sold 3,348 shares at $12.07 ($40,421)
- 4 Exercise or conversion SVP & Chief Commercial Officer acquired 9,375 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 25,000 shares (option exercise)
- 4 Exercise or conversion SVP, CFO, Sec & Treasurer acquired 9,375 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 15 of 29 · 579 filings